Vienna, Austria

Walter G Schmidt

This inventor holds 23 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Alzheimer's Disease Treatment. Top assignees: Affiris Ag, Intercell Ag, Boehringer Ingelheim International Gmbh. Active years: 1996-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter G Schmidt. Retrieved from https://idiyas.com/inventor/walter-g-schmidt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 60.9

 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 407(Granted Patents)


Location History:

  • Steingasse, AT (2000)
  • Vienna, AT (1996 - 2021)

Company Filing History:


Years Active: 1996-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Alzheimer's Disease
Immunostimulatory Oligodeoxynucleotides
Vaccine
Cholesterol Ester Transport Protein
Apheresis Device
Combination Therapy
Pharmaceutical Composition
Nucleic Acid Complexes
Antigenic Composition
Peptides
Adjuvants
Endosomolytic Agent
23 patents (USPTO):Explore Patents

Title: Walter G Schmidt: Innovator in Alzheimer's Disease Treatment

Introduction

Walter G Schmidt is a prominent inventor based in Vienna, Austria, known for his significant contributions to the field of medical innovations, particularly in the treatment of Alzheimer's Disease (AD). With a remarkable portfolio of 23 patents, Schmidt’s work has advanced the understanding and treatment options available for this challenging neurodegenerative condition.

Latest Patents

Among his latest patents, Schmidt has developed innovative methods leveraging aluminum salts to treat Alzheimer's Disease. One of his notable inventions involves an immune-stimulating pharmaceutical composition that comprises an aluminum salt, which is administered to patients suffering from AD or those at risk of developing it. This approach aims to enhance the immune response against the disease. Additionally, he has disclosed an aluminum salt specifically for the treatment and prevention of dementias associated with β-amyloid deposition, with a clear focus on Alzheimer's Disease.

Career Highlights

Walter G Schmidt has made a substantial impact during his career, particularly through his roles at leading companies such as Affiris AG and Intercell AG. His expertise and innovative mindset have driven advancements in the pharmaceutical landscape, focusing on novel therapeutic solutions and enhancing patient care.

Collaborations

Throughout his career, Schmidt has collaborated with esteemed colleagues, including Frank Mattner and Max L Birnstiel. These partnerships have facilitated research and development, leading to significant breakthroughs in the understanding and treatment of Alzheimer's Disease.

Conclusion

Walter G Schmidt's extensive patent portfolio and collaborative efforts signify his dedication and impact in the medical field. His innovative approaches to treating Alzheimer's Disease highlight the potential for new therapies to improve the lives of patients affected by this condition. As he continues to explore the therapeutic possibilities of aluminum salts, Schmidt remains a pivotal figure in the ongoing battle against Alzheimer's Disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…